M1 Kliniken AG
XETRA:M12
Intrinsic Value
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. [ Read More ]
The intrinsic value of one M12 stock under the Base Case scenario is 12.73 EUR. Compared to the current market price of 13.85 EUR, M1 Kliniken AG is Overvalued by 8%.
Valuation Backtest
M1 Kliniken AG
Run backtest to discover the historical profit from buying and selling M12 stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
M1 Kliniken AG
Current Assets | 115.3m |
Cash & Short-Term Investments | 49m |
Receivables | 35.7m |
Other Current Assets | 30.5m |
Non-Current Assets | 87.9m |
Long-Term Investments | 12m |
PP&E | 15.4m |
Intangibles | 60.2m |
Other Non-Current Assets | 274.3k |
Current Liabilities | 42.2m |
Accounts Payable | 24m |
Other Current Liabilities | 18.2m |
Non-Current Liabilities | 14.7m |
Long-Term Debt | 11.4m |
Other Non-Current Liabilities | 3.3m |
Earnings Waterfall
M1 Kliniken AG
Revenue
|
297.4m
EUR
|
Cost of Revenue
|
-247m
EUR
|
Gross Profit
|
50.4m
EUR
|
Operating Expenses
|
-38.2m
EUR
|
Operating Income
|
12.2m
EUR
|
Other Expenses
|
-5.8m
EUR
|
Net Income
|
6.4m
EUR
|
Free Cash Flow Analysis
M1 Kliniken AG
What is Free Cash Flow?
M12 Profitability Score
Profitability Due Diligence
M1 Kliniken AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
M1 Kliniken AG's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
M12 Solvency Score
Solvency Due Diligence
M1 Kliniken AG's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Score
M1 Kliniken AG's solvency score is 91/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
M12 Price Targets Summary
M1 Kliniken AG
According to Wall Street analysts, the average 1-year price target for M12 is 14.89 EUR with a low forecast of 11.92 EUR and a high forecast of 18.9 EUR.
Shareholder Return
M12 Price
M1 Kliniken AG
Average Annual Return | -8.27% |
Standard Deviation of Annual Returns | 23.29% |
Max Drawdown | -78% |
Market Capitalization | 272.1m EUR |
Shares Outstanding | 18 315 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
M1 Kliniken AG engages in the provision of medical services in the field of beauty sector. The company is headquartered in Berlin, Berlin. The company went IPO on 2015-09-14. The firm operates a chain of medical centers for aesthetic and plastic treatments, such as wrinkle treatments, lip treatments, breast corrections, liposuction, tummy tucks, upper arm lift, upper thigh lift, face lift, upper eyelid lift and the correction of labia, among others. In addition, the Company provides consultation services with registered doctors and specialists. The company operates medical centers in Berlin, Essen, Dusseldorf, Cologne and Munich.
Contact
IPO
Employees
Officers
The intrinsic value of one M12 stock under the Base Case scenario is 12.73 EUR.
Compared to the current market price of 13.85 EUR, M1 Kliniken AG is Overvalued by 8%.